LungLife AI, Inc. (LON:LLAI) Insider Paul Carmelo Pagano Acquires 12,123 Shares of Stock

LungLife AI, Inc. (LON:LLAI – Get Free Report) insider Paul Carmelo Pagano acquired 12,123 shares of the stock in a transaction dated Monday, August 14th. The stock was acquired at an average price of GBX 70 ($0.89) per share, with a total value of £8,486.10 ($10,765.06).

LungLife AI Trading Up 5.9 %

LON:LLAI opened at GBX 81 ($1.03) on Tuesday. The company has a fifty day moving average of GBX 39.92 and a 200 day moving average of GBX 59.87. LungLife AI, Inc. has a 52 week low of GBX 19 ($0.24) and a 52 week high of GBX 137.57 ($1.75). The company has a quick ratio of 9.85, a current ratio of 4.08 and a debt-to-equity ratio of 4.53. The firm has a market capitalization of £20.65 million, a P/E ratio of -300.00 and a beta of 0.55.

Get LungLife AI alerts:

About LungLife AI

(Get Free Report)

LungLife AI, Inc, a diagnostic company, researches and develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology in the United States and the People's Republic of China. It engages in developing LungLB, a blood-based test to stratify cancerous and benign lung nodules identified by CT scan.

Read More

• Five stocks we like better than LungLife AI
• What is Put Option Volume?
• 3 Sizzling Dividends That Are Going On Sale
• Unveiling The Power Of VWAP: A Key Indicator For Traders
• 3 Ways To Trade, Trade Desk Stock Post Earnings
• Investing in Travel Stocks Benefits
• Inflation, The Fed, and Oil Prices: Interest Rates Are Going Up

Receive News & Ratings for LungLife AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LungLife AI and related companies with MarketBeat.com's FREE daily email newsletter.